Contingencies and commitments - Universal Cells Research, Collaboration and License Agreement and Co-development and Co-commercialization agreement (Details) - Collaboration and license agreement - Universal Cells, Inc. - USD ($) |
1 Months Ended | 9 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|
Feb. 29, 2016 |
Nov. 30, 2015 |
Sep. 30, 2022 |
Dec. 31, 2018 |
Dec. 31, 2017 |
|
| Contingencies and commitments | |||||
| Upfront license and start-up fees | $ 2,500,000 | ||||
| Milestone payments | $ 3,000,000 | $ 500,000 | $ 200,000 | $ 900,000 | |
| Milestone payment invoiced but not paid | 400,000 | ||||
| Maximum | |||||
| Contingencies and commitments | |||||
| Potential milestone payments | 35,300,000 | ||||
| Milestone payment accrued but not yet paid | 1,800,000 | ||||
| Milestone payment invoiced but not paid | $ 600,000 | ||||
| X | ||||||||||
- Definition Represents the amount of payments that the entity is required to make under the agreement, upon achievement of certain development and product milestones. No definition available.
|
| X | ||||||||||
- Definition The amount of milestone payment accrued but not yet paid. No definition available.
|
| X | ||||||||||
- Definition The amount of milestone payment invoiced but not yet paid. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of milestone payments made by the entity under the license agreement. No definition available.
|
| X | ||||||||||
- Definition Represents the amount of upfront and start-up fees paid. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|